Canada markets open in 8 hours 31 minutes

Nascent Biotech, Inc. (NBIO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
0.0900-0.0090 (-9.09%)
At close: 03:14PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
0
0
1,000
750
0
Operating Expenses
Research Development
183.414
270.529
197.406
321.938
293.709
Selling General and Administrative
1,670
1,502
927.357
1,828
3,154
Total Operating Expenses
2,238
2,156
1,457
2,150
3,447
Operating Income or Loss
-2,238
-2,156
-457.052
-1,400
-3,447
Interest Expense
1,091
1,723
335.983
336.632
86.632
Total Other Income/Expenses Net
942.836
1,083
473.823
797.644
-470.216
Income Before Tax
-2,093
-2,801
-470.39
-958.767
-4,004
Income Tax Expense
-
0
0
0
0
Income from Continuing Operations
-2,093
-2,801
-470.39
-958.767
-4,004
Net Income
-2,093
-2,801
-470.39
-958.767
-4,004
Net Income available to common shareholders
-2,093
-2,801
-470.39
-958.767
-4,004
Basic EPS
-0.02
-0.02
-0.00
-0.01
-0.12
Diluted EPS
-0.02
-0.02
-0.00
-0.01
-0.12
Basic Average Shares
132,544
118,569
107,742
72,342
34,393
Diluted Average Shares
132,544
118,569
107,742
72,342
34,393